BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 15726600)

  • 1. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
    Stinnett JM; Pendleton R; Skordos L; Wheeler M; Rodgers GM
    Am J Hematol; 2005 Mar; 78(3):167-72. PubMed ID: 15726600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM; Kolansky DM; Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism: application and effectiveness of the American College of Chest Physicians 2001 guidelines for prophylaxis.
    Steier KJ; Singh G; Ullah A; Maneja J; Ha RS; Khan F
    J Am Osteopath Assoc; 2006 Jul; 106(7):388-95. PubMed ID: 16912336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolic prophylaxis in hospitalized medical patients.
    Stark JE; Kilzer WJ
    Ann Pharmacother; 2004 Jan; 38(1):36-40. PubMed ID: 14742790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological thromboembolic prophylaxis for medical patients in a tertiary care, teaching community hospital: room for improvement.
    Jubelirer SJ; Reyes Bj; Broce M; Elhabyan AK; Mimnagh K; Rosencrance JG; Warwick T; Emmett MK
    W V Med J; 2008; 104(1):10-4. PubMed ID: 18335779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thromboembolic risk and prophylaxis in hospitalized surgical and internal medicine patients. German results of the international ENDORSE study].
    Zotz RB; Kauschat-Brüning D; Bramlage P;
    Dtsch Med Wochenschr; 2009 Oct; 134(43):2163-9. PubMed ID: 19826978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis against venous thromboembolism in hospitalized medically ill patients.
    Pendergraft T; Liu X; Edelsberg J; Phatak H; Vera-Llonch M; Liu LZ; Oster G
    Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):75-82. PubMed ID: 23300270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.
    Alikhan R; Cohen AT; Combe S; Samama MM; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Olsson CG; Turpie AG;
    Arch Intern Med; 2004 May; 164(9):963-8. PubMed ID: 15136304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicians' practice for prevention of venous thromboembolism in medical patients.
    Abba AA; Al Ghonaim MA; Rufai AM
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):211-4. PubMed ID: 15228823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.
    Robertson MS; Nichol AD; Higgins AM; Bailey MJ; Presneill JJ; Cooper DJ; Webb SA; McArthur C; MacIsaac CM; ;
    Crit Care Resusc; 2010 Mar; 12(1):9-15. PubMed ID: 20196708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thromboembolic prophylaxis in hospitalized medical patients].
    Braekkan S; Grimsgaard S; Hansen JB
    Tidsskr Nor Laegeforen; 2007 May; 127(9):1177-80. PubMed ID: 17479133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism prophylaxis and clinical consequences in medically ill patients.
    Baser O; Liu X; Phatak H; Wang L; Mardekian J; Kawabata H; Petersel D; Hamilton M; Ramacciotti E
    Am J Ther; 2013; 20(2):132-42. PubMed ID: 23466619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of venous thromboembolism in medically ill patients: a clinical update.
    Turpie AG; Leizorovicz A
    Postgrad Med J; 2006 Dec; 82(974):806-9. PubMed ID: 17148703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows.
    Scaglione L; Piobbici M; Pagano E; Ballini L; Tamponi G; Ciccone G
    Haematologica; 2005 May; 90(5):678-84. PubMed ID: 15921383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital-acquired venous thromboembolism and prophylaxis in an integrated hospital delivery system.
    Dorfman M; Chan SB; Maslowski C
    J Clin Pharm Ther; 2006 Oct; 31(5):455-9. PubMed ID: 16958823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
    Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
    Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.